The goal of this study is to determine the safety (but not efficacy in preventing infection)
of sterile-packaged and pre-loaded injectable solutions of both vancomycin and moxifloxacin
at certain dosages and concentrations as prepared by a compounding pharmacy when used
intracamerally at the time of cataract surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Panhandle Eye Group, LLP
Treatments:
Anti-Bacterial Agents Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination Vancomycin